Loading clinical trials...

TERMINATEDPhase 2NCT00982150

Extension Study of Talampanel for Amyotrophic Lateral Sclerosis (ALS)

This will be an open label treatment extension phase in patients with ALS who have previously participated in the double blind, placebo-controlled ALS-TAL-201 study. This study will make talampanel tr...

Lead sponsor: Teva Branded Pharmaceutical Products R&D, Inc.•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

RECRUITINGPhase 2

Tofersen in Non-SOD1 ALS

NCT07294144 · ALS (Amyotrophic Lateral Sclerosis)

RECRUITING

Healing ALS Registry Observational Study (HAROS)

NCT07233148 · Amyotrophic Lateral Sclerosis (ALS), Motor Neuron Disease (MND), and more

RECRUITINGPhase 1

A Substudy of LY4256984 in Participants With Sporadic Amyotrophic Lateral Sclerosis

NCT07571174 · Amyotrophic Lateral Sclerosis

RECRUITINGPhase 1/2

A Study of LTX-002 in Adult Participants With Amyotrophic Lateral Sclerosis

NCT07660614 · Amyotrophic Lateral Sclerosis

RECRUITINGPhase 1/2

A Clinical Trial to Evaluate NB-4746 in Participants With Amyotrophic Lateral Sclerosis.

NCT07369076 · Amyotrophic Lateral Sclerosis (ALS)

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: August 26, 2013Terms

Trial snapshot

StatusTERMINATED

PhasePHASE2

Enrollment446

Start dateSep 2009

Last updatedAug 26, 2013

Condition

Amyotrophic Lateral Sclerosis

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: August 26, 2013Data synced to Clareo: July 13, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions